Table 2.
Route | Delivery site | Convenience to patients | Probability of adverse events | Applicability to CNS delivery of naked ODNs |
---|---|---|---|---|
Oral (PO) | By mouth | ++++++ | + | − |
Intranasal | Inhalation or application of gel/liquid formulation inside the nose | ++++++ | + | ++ |
Subcutaneous injection (SC) | Intra-skin injection | ++++ | ++ | − |
Intraperitoneal injection (IP) | Injection into body cavity | ++ | +++ | − |
Intramuscular injection (IM) | Injection deep into the muscle | +++ | +++ | N.A. |
Intravenous injection (IV) | Injection directly into vein | +++ | ++++ | − |
Intrathecal injection (IT) | Injection through brain/spinal cord sheath, usually between lumbar vertebrae | ++ | +++++ | ++++++ |
Intracerebroventricular injection (ICV) | Injection deep inside the brain, into a ventricle, requires brain surgery to install a catheter | + | ++++++++ | ++++++ |
+, high; N.A., not applicable; −, low